2024 AUA preview: Dr. Tawagi on top research in bladder cancer
Karine Tawagi, MD, highlights several studies in bladder cancer being presented at the 2024 American Urological Association Annual Meeting.
Karine Tawagi, MD, highlights several studies in bladder cancer being presented at the 2024 American Urological Association Annual Meeting.
AUA 2024 advanced prostate cancer, molecular imaging (mi) node positive disease (miN1) undergoing radical prostatectomy, extended pelvic lymph node dissection (ePLND).
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
Extended lymph node dissection during radical cystectomy offered no additional overall survival or disease-free survival benefit vs standard lymph node dissection.
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
The 2024 AUA Annual Meeting program will offer more education and innovative programming than ever before! Join us in San Antonio.
renal mass, renal cell carcinoma (RCC), kidney cancer, Partial Nephrectomy (PN), Radical Nephrectomy (RN), renal mass in a solitary kidney (RMSK), chronic kidney disease (CKD),…
The AUA invites the global urologic community to the 119th AUA Annual Meeting in the dynamic city of San Antonio, TX!
The geographic distribution of the malignancy in Finland provided a clue to an upward trend.
Treatment with apalutamide and androgen deprivation therapy led to a 2-year biochemical recurrence-free survival rate of 100% in patients with high-risk, post-prostatectomy prostate cancer.